Piascledine 300mg capsule is indicated for the symptomatic slow-acting treatment of hip and knee osteoarthritis.
PIASCLEDINE 300 is a patented, clinically proven treatment for osteoarthritis.
The ONLY clinically proven treatment that :
Slows disease progression
Has no known drug interactions
Reduces the need for harmful anti-inflammatories
PIASCLEDINE 300 have a unique and proven dual mode of action , prevents cartilage breakdown and stimulates cartilage repair.
In clinical studies conducted with patients suffering from hip and knee osteoarthritis, patients given PIASCLEDINE 300 noticed improvements in symptoms within only one month and were less likely to resume non-steroidal anti-inflammatory drug (NSAID) therapy after only six weeks of treatment. PIASCLEDINE 300 was also shown to reduce pain and improve function after only two months of treatment.
One capsule daily. An increase in daily dosage to 2 capsules daily did not evidence any increase in efficacy. The usual treatment duration is between 3 to 6 months.
No special action is needed if one or more dose(s) are missed.
Method of administration:
Oral use. Capsule is to be swallowed as a whole, without chewing, with a glass of water, generally in the middle of a meal.
PIASCLEDINE 300 is composed of a mixture of soyabean oil unsaponifiables and specific avocado oil unsaponifiables.
This is a unique process that has been patented by Laboratoires Expanscience, a leading pharmaceutical company from France.